Considerations for physicians using ketamine for sedation of children in emergency departments

Woo Sung Kim1, Ji Yeon Ku1, Hanbyul Choi2

  • 1Department of Emergency Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

Insights

Younger pediatric patients receiving ketamine for procedural sedation in the emergency department experienced more adverse events. Intravenous administration and higher ketamine doses were significant factors associated with these events.

Area of Science:

  • Emergency Medicine
  • Pediatric Sedation
  • Pharmacology

Background:

  • Ketamine is increasingly used for procedural sedation and analgesia in emergency departments (EDs).
  • Limited research exists on patient-specific factors influencing adverse events in pediatric ketamine sedation.
  • This study addresses the need to identify factors for safe ketamine use in children within the ED setting.

Purpose of the Study:

  • To investigate patient factors associated with adverse events in pediatric patients undergoing ketamine sedation for laceration repair in the ED.
  • To identify key variables that emergency medicine physicians should consider to optimize ketamine administration in children.

Main Methods:

  • A cohort of 116 pediatric patients (8 months to 7 years) receiving ketamine for ED laceration repair was studied.
  • Data collected included age, upper respiratory tract infection symptoms, allergy history, and fasting status.
  • Ketamine was administered intravenously (2 mg/kg) or intramuscularly (4 mg/kg), with adverse events as the primary outcome.

Main Results:

  • Younger patients (mean age 2.5 years) were significantly more likely to experience adverse events compared to older patients (mean age 3.1 years).
  • Higher ketamine doses and intravenous administration were significantly correlated with adverse events.
  • Factors such as upper respiratory tract infection symptoms, fasting duration, and food type were not significant predictors of adverse events.

Conclusions:

  • Emergency medicine physicians should carefully consider ketamine dose and injection route (intravenous vs. intramuscular) when sedating pediatric patients for laceration repair.
  • Younger age is a significant factor associated with increased risk of adverse events during ketamine sedation.
  • Further research may explore optimal dosing and administration strategies to minimize adverse events in pediatric procedural sedation.
Abstract

Related Concept Videos

Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
761
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.6K
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.1K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
964
Design Consideration01:22

Design Consideration

Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
588
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
628